RCAG
IMGN

Rehmann Capital Advisory Group’s Immunogen Inc IMGN Stock Holding History

Rehmann Capital Advisory Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-48
Closed -$104 – 2191
2019
Q2 		$104 Hold
48
– – ﹤0.01% 2048
2019
Q1 		$130 Hold
48
– – ﹤0.01% 2061
2018
Q4 		$230 Hold
48
– – ﹤0.01% 1792
2018
Q3 		$454 Hold
48
– – ﹤0.01% 2070
2018
Q2 		$467 Hold
48
– – ﹤0.01% 2057
2018
Q1 		$1K Buy
+48
New +$474 ﹤0.01% 1953

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rehmann Capital Advisory Group's IMGN Position: Q3 2019 in Review

Rehmann Capital Advisory Group sold out of Immunogen Inc (IMGN) in Q3 2019, closing a stake of 48 shares — an estimated $104 sold.

Rehmann Capital Advisory Group first reported a position in IMGN in Q1 2018 and held it in 6 quarters. The position peaked at $1K in Q1 2018. 189 funds tracked by Wall St. Rank hold IMGN as of Q3 2019.

  • Rehmann Capital Advisory Group reported no remaining Immunogen Inc position as of Q3 2019 after selling out during the quarter.
  • Rehmann Capital Advisory Group sold 48 Immunogen Inc shares in Q3 2019, an estimated $104.
  • Rehmann Capital Advisory Group first reported a position in Immunogen Inc in Q1 2018 and held it in 6 quarters.
  • Rehmann Capital Advisory Group's Immunogen Inc position peaked at $1K in Q1 2018.
  • 189 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.